Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,341 to 1,360 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods. | Comput Math Methods Med | 2022 | 35774297 | PubTator, text mining | PubMed |
| Systemic Relapse in a Young Adult Patient with Primary CNS Diffuse Large B-Cell Lymphoma. | Case Rep Hematol | 2022 | 35774056 | PubTator, text mining | PubMed |
| Frequent aneuploidy in primary human T cells after CRISPR-Cas9 cleavage. | Nat Biotechnol | 2022 | 35773341 | PubTator, text mining | PubMed |
| circRNA: Regulatory factors and potential therapeutic targets in inflammatory dermatoses. | J Cell Mol Med | 2022 | 35770323 | PubTator, text mining | PubMed |
| PLCE1 is a poor prognostic marker and may promote immune escape from osteosarcoma by the CD70-CD27 signaling pathway. | Bosn J Basic Med Sci | 2022 | 35765945 | PubTator, text mining | PubMed |
| CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges. | Front Immunol | 2022 | 35757715 | PubTator, text mining | PubMed |
| Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia. | Molecules | 2022 | 35745032 | PubTator, text mining | PubMed |
| CAR T Cell Locomotion in Solid Tumor Microenvironment. | Cells | 2022 | 35741103 | PubTator, text mining | PubMed |
| Competitive Hybridization of a Microarray Identifies CMKLR1 as an Up-Regulated Gene in Human Bone Marrow-Derived Mesenchymal Stem Cells Compared to Human Embryonic Fibroblasts. | Curr Issues Mol Biol | 2022 | 35723360 | PubTator, text mining | PubMed |
| Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients With Herpes Zoster and Postherpetic Neuralgia. | Front Immunol | 2022 | 35720399 | PubTator, text mining | PubMed |
| A Global Regulatory Network for Dysregulated Gene Expression and Abnormal Metabolic Signaling in Immune Cells in the Microenvironment of Graves' Disease and Hashimoto's Thyroiditis. | Front Immunol | 2022 | 35720300 | PubTator, text mining | PubMed |
| One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia. | Front Immunol | 2022 | 35720276 | PubTator, text mining | PubMed |
| Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma. | Front Oncol | 2022 | 35719911 | PubTator, text mining | PubMed |
| iRECIST and atypical patterns of response to immuno-oncology drugs. | J Immunother Cancer | 2022 | 35715004 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection in patients with inborn errors of immunity due to DNA repair defects. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35713311 | PubTator, text mining | PubMed |
| GLUT1 Regulates the Tumor Immune Microenvironment and Promotes Tumor Metastasis in Pancreatic Adenocarcinoma via ncRNA-mediated Network. | J Cancer | 2022 | 35711842 | PubTator, text mining | PubMed |
| Identification of a novel prognostic signature for HCC and analysis of costimulatory molecule-related lncRNA AC099850.3. | Sci Rep | 2022 | 35705628 | PubTator, text mining | PubMed |
| Characterization of multiple soluble immune checkpoints in individuals with different Mycobacterium tuberculosis infection status and dynamic changes during anti-tuberculosis treatment. | BMC Infect Dis | 2022 | 35701741 | PubTator, text mining | PubMed |
| Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma. | Front Cell Dev Biol | 2022 | 35693941 | PubTator, text mining | PubMed |
| Past, Present and Future: The Relationship Between Circular RNA and Immunity. | Front Immunol | 2022 | 35693804 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=68